Literature DB >> 8273774

Immunohistochemical expression of carbohydrate antigen 19-9 in colorectal carcinoma.

R Shimono1, M Mori, K Akazawa, Y Adachi, K Sgimachi.   

Abstract

OBJECTIVES: Carbohydrate antigen 19-9 (CA19-9) is one of the most representative tumor markers in colorectal carcinomas. We studied the immunohistochemical expression of CA19-9 in primary colorectal carcinoma to identify its significance as a prognostic factor.
METHODS: The avidin-biotin-peroxidase complex method was used for CA19-9 staining in sections from 149 patients with primary colorectal carcinoma. The data were studied by univariate and multivariate analyses.
RESULTS: 86 tumors (56%) stained positively. The staining pattern was classified into three groups: group I (a stromal type, 22 tumors), group II (an apical and/or cytoplasmic type, 64 tumors), and group III (no staining, 63 tumors). Eight clinicopathologic variables showed a significant relationship with the staining pattern of CA19-9. The 5-yr survival rate of the group I subjects was significantly lower than that of the other two groups. With the multivariate analysis, the staining pattern of CA19-9 proved to be one of the independent prognostic variables.
CONCLUSIONS: In addition to conventional prognostic factors, the staining pattern of CA19-9 is considered to be of value in predicting the prognosis of patients with colorectal carcinomas.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8273774

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

1.  The prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer.

Authors:  C X Zheng; W H Zhan; J Z Zhao; D Zheng; D P Wang; Y L He; Z Q Zheng
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

Review 2.  Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer.

Authors:  R Kannagi
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

3.  Association of serum levels of CEA, CA199, CA125, CYFRA21-1 and CA72-4 and disease characteristics in colorectal cancer.

Authors:  Wa Zhong; Zhong Yu; Jun Zhan; Tao Yu; Ying Lin; Zhong-Sheng Xia; Yu-Hong Yuan; Qi-Kui Chen
Journal:  Pathol Oncol Res       Date:  2014-05-30       Impact factor: 3.201

4.  High preoperative serum CA 19-9 levels can predict poor oncologic outcomes in colorectal cancer patients on propensity score analysis.

Authors:  Jung Kyong Shin; Hee Cheol Kim; Woo Yong Lee; Seong Hyeon Yun; Yong Beom Cho; Jung Wook Huh; Yoon Ah Park; Ho-Kyung Chun
Journal:  Ann Surg Treat Res       Date:  2018-02-26       Impact factor: 1.859

5.  N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation.

Authors:  Crina I A Balog; Kathrin Stavenhagen; Wesley L J Fung; Carolien A Koeleman; Liam A McDonnell; Aswin Verhoeven; Wilma E Mesker; Rob A E M Tollenaar; André M Deelder; Manfred Wuhrer
Journal:  Mol Cell Proteomics       Date:  2012-05-09       Impact factor: 5.911

Review 6.  Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology.

Authors:  Elisabete Fernandes; Janine Sores; Sofia Cotton; Andreia Peixoto; Dylan Ferreira; Rui Freitas; Celso A Reis; Lúcio Lara Santos; José Alexandre Ferreira
Journal:  Theranostics       Date:  2020-03-31       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.